Bruce D. Forrest, MD, MBA brings over 30 years of global leadership in pharmaceutical development June 22, 2022 10:15 ET | Source: Skymount Medical, Inc. CALGARY, Alberta and NEW ORLEANS, June 22, 2022 (GLOBE NEWSWIRE) — Skymount Medical, a drug … Read More
News
IN THE NEWS
The Best Time to Plant A Tree Was Twenty Years Ago
May 31, 2022 | Source: Business in Edmonton It is hard to keep up with all of the incredible things going on in Alberta these days. One of the shining lights is the development of our expertise in Artificial intelligence … Read More
Skymount Medical Wins Silver Stevie® Award for Its LSU-Developed DeepDrug™ Artificial Intelligence Platform to Accelerate Drug Discovery
CALGARY, AB and BATON ROUGE, La.— May 31, 2022 — Skymount Medical, a drug discovery company using an artificial intelligence (AI) platform developed by Louisiana State University (LSU) researchers to repurpose and build new drugs for innovative new therapies, announced … Read More
Skymount Medical Receives UK MHRA Approval to Test New Treatment in Patients with Mild to Moderate COVID-19
— MHRA grants permission for UK clinical trials for AI-discovered drug combination that reduces length and severity of symptoms and could lower hospitalizations — — Approval expands Skymount Medical’s global reach — CALGARY, Alberta and BATON ROGUE, La., Feb. 22, … Read More
Riverside University Health System Medical Center, Skymount Medical Begin U.S. Clinical Trial for COVID-19 Oral Therapeutics Discovered Using Artificial Intelligence
CALGARY, AB and MORENO VALLEY, Calif. and BATON ROUGE, La., Nov. 3, 2021 /PRNewswire/ — Skymount Medical has partnered with Riverside University Health System (RUHS) Medical Center to conduct the first U.S. clinical trial on the efficacy of COVID-19 oral … Read More
EN NEWS Global Orphan Diseases Under-Medicated and Over-Medicalized, Professor Kishor Wasan Says
Achieving a global standard of health requires creating new pharmaceutical tools says Professor Kishor Wasan Global Orphan Diseases Under-Medicated and Over-Medicalized, Professor Kishor Wasan Said SASKATOON, SK, CANADA, October 13, 2021 /EINPresswire.com/ — If you live in Canada, the United … Read More
Austin’s Big Race Weekend Shifts Into High Gear With Club SI
AUSTIN, Texas, Oct. 8, 2021 /PRNewswire/ — Austin’s Big Race Weekend shifts into high gear with the launch of Club SI, an upscale and unforgettable experience. Club SI at COTA will feature appearances from celebrity guests and tastemakers, an upscale party atmosphere, … Read More
AI-Derived Inhibinol™ Leads the Way for Next Generation of Consumer Health Products
PRNewswire Article CALGARY, AB. and BATON ROUGE, La., Sept. 21, 2021 /PRNewswire/ — At a time when global health and dietary challenges require rapid cutting-edge technologies and innovation to improve well-being, Skymount Medical, using research developed at Louisiana State University (LSU), announces the launch of … Read More
Health Tech: Chris Galliano On How Skymount Medical’s Technology Can Make an Important Impact on Our Overall Wellness
Medium.com Authority Magazine Article To that end, be open to and seek to learn more about all different kinds of disciplines, so the technology has as many building blocks as possible to build an effective solution. DeepDrug draws on … Read More
5 latest innovations in the fight against COVID-19
HealthcareGlobal.com Article The COVID-19 pandemic was declared almost 18 months ago. In that time the scientific community has rallied to produce a variety of tests and several effective vaccines along with a number of other innovations. Here we take a look … Read More
Human studies begin on artificial Intelligence discovered COVID-19 treatment with up to 97 percent effectiveness
PR Newswire Article CALGARY, AB. and BATON ROUGE, La., Aug. 11, 2021 /PRNewswire/ — Skymount Medical, a drug discovery company, and Louisiana State University (LSU) announced today that human studies have begun on its unique combination of therapies, known as SM-19, for COVID-19 patients. In vitro (cell) and in … Read More
iCo Therapeutics Announces Joint Development of iCo-019 with Skymount Medical
NewsFileCorp Article Vancouver, British Columbia–(Newsfile Corp. – December 31, 2020) – iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF) (“iCo” or the “Company”), iCo Therapeutics, Inc. (“iCo”) and Skymount Medical, Inc. (“Skymount”) announced today that they have entered into a non-binding Memorandum … Read More